
Sergio Coffa
Examiner (ID: 9524, Phone: (571)270-3022 , Office: P/1675 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658, 1654, 1675 |
| Total Applications | 897 |
| Issued Applications | 440 |
| Pending Applications | 134 |
| Abandoned Applications | 351 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6349272
[patent_doc_number] => 20100249023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'ISOFLAVONE FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 12/677785
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7859
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249023.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677785
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677785 | ISOFLAVONE FORMULATION | Sep 11, 2008 | Abandoned |
Array
(
[id] => 6535637
[patent_doc_number] => 20100204155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'USE OF THE PEPTIDE SFLLR-OH AND MURAMYL DIPEPTIDE AS THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/677318
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35091
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204155.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677318 | USE OF THE PEPTIDE SFLLR-OH AND MURAMYL DIPEPTIDE AS THERAPEUTIC AGENTS | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6223679
[patent_doc_number] => 20100181197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'ISOELECTRIC POINT MARKERS'
[patent_app_type] => utility
[patent_app_number] => 12/668686
[patent_app_country] => US
[patent_app_date] => 2008-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9452
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20100181197.pdf
[firstpage_image] =>[orig_patent_app_number] => 12668686
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668686 | ISOELECTRIC POINT MARKERS | Jul 13, 2008 | Abandoned |
Array
(
[id] => 6177350
[patent_doc_number] => 20110177998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'BIOACTIVE PEPTIDES AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/668712
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 36479
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177998.pdf
[firstpage_image] =>[orig_patent_app_number] => 12668712
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668712 | Bioactive peptides and methods of using same | Jul 10, 2008 | Issued |
Array
(
[id] => 6538485
[patent_doc_number] => 20100221749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'THREE-FUNCTIONAL PSEUDO-PEPTIDIC REAGENT, AND USES AND APPLICATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/668518
[patent_app_country] => US
[patent_app_date] => 2008-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16278
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221749.pdf
[firstpage_image] =>[orig_patent_app_number] => 12668518
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668518 | THREE-FUNCTIONAL PSEUDO-PEPTIDIC REAGENT, AND USES AND APPLICATIONS THEREOF | Jul 9, 2008 | Abandoned |
Array
(
[id] => 6231547
[patent_doc_number] => 20100184703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'USE OF PEPTIDE DERIVATIVES FOR TREATING PATHOLOGIES RESULTING FROM ISCHEMIA'
[patent_app_type] => utility
[patent_app_number] => 12/666462
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7776
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184703.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666462
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666462 | USE OF PEPTIDE DERIVATIVES FOR TREATING PATHOLOGIES RESULTING FROM ISCHEMIA | Jun 26, 2008 | Abandoned |
Array
(
[id] => 6531148
[patent_doc_number] => 20100221272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'IMMUNOMODULATORY COMPOSITIONS AND METHODS FOR TREATING DISEASE WITH MODIFIED HOST DEFENSE PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/666229
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23862
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221272.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666229
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666229 | Immunomodulatory compositions and methods for treating disease with modified host defense peptides | Jun 26, 2008 | Issued |
Array
(
[id] => 7711789
[patent_doc_number] => 20120004157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'HYDROXYPROLINE COMPOSITIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/451940
[patent_app_country] => US
[patent_app_date] => 2008-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 119134
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12451940
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/451940 | HYDROXYPROLINE COMPOSITIONS AND USES THEREOF | Jun 5, 2008 | Abandoned |
Array
(
[id] => 6326757
[patent_doc_number] => 20100197578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'DEMANNOSYLATED RECOMBINANT FACTOR VIII [[VII]] FOR THE TREATMENT OF PATIENTS WITH HAEMOPHILIA A'
[patent_app_type] => utility
[patent_app_number] => 12/596323
[patent_app_country] => US
[patent_app_date] => 2008-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16168
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197578.pdf
[firstpage_image] =>[orig_patent_app_number] => 12596323
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/596323 | Demannosylated recombinant factor VIII for the treatment of patients with haemophilia A | Apr 20, 2008 | Issued |
Array
(
[id] => 6436992
[patent_doc_number] => 20100143964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'COMPOSITIONS AND METHODS FOR CONCENTRATING AND DEPLETING MICROORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 12/448214
[patent_app_country] => US
[patent_app_date] => 2007-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 24726
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143964.pdf
[firstpage_image] =>[orig_patent_app_number] => 12448214
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/448214 | Compositions and methods for concentrating and depleting microorganisms | Dec 12, 2007 | Issued |
Array
(
[id] => 34542
[patent_doc_number] => 07791715
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-09-07
[patent_title] => 'Method and system for lossless dealiasing in time-of-flight (TOF) systems'
[patent_app_type] => utility
[patent_app_number] => 11/906609
[patent_app_country] => US
[patent_app_date] => 2007-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 8423
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/791/07791715.pdf
[firstpage_image] =>[orig_patent_app_number] => 11906609
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/906609 | Method and system for lossless dealiasing in time-of-flight (TOF) systems | Oct 1, 2007 | Issued |
Array
(
[id] => 6320273
[patent_doc_number] => 20100113326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'DIMERIC IAP INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/374724
[patent_app_country] => US
[patent_app_date] => 2007-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15469
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113326.pdf
[firstpage_image] =>[orig_patent_app_number] => 12374724
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/374724 | DIMERIC IAP INHIBITORS | Jul 23, 2007 | Abandoned |
Array
(
[id] => 5028897
[patent_doc_number] => 20070270344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Compositions and methods for treating ophthalmic disorders'
[patent_app_type] => utility
[patent_app_number] => 11/724197
[patent_app_country] => US
[patent_app_date] => 2007-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14842
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270344.pdf
[firstpage_image] =>[orig_patent_app_number] => 11724197
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/724197 | Compositions and methods for treating ophthalmic disorders | Mar 14, 2007 | Abandoned |
Array
(
[id] => 5290933
[patent_doc_number] => 20090023663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Thymosin beta 4 compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/715997
[patent_app_country] => US
[patent_app_date] => 2007-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11747
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023663.pdf
[firstpage_image] =>[orig_patent_app_number] => 11715997
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/715997 | Thymosin beta 4 compositions and methods | Mar 8, 2007 | Abandoned |
Array
(
[id] => 4676033
[patent_doc_number] => 20080213663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'DIGITAL ALLOYS AND METHODS FOR FORMING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/679726
[patent_app_country] => US
[patent_app_date] => 2007-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14877
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213663.pdf
[firstpage_image] =>[orig_patent_app_number] => 11679726
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/679726 | Digital alloys and methods for forming the same | Feb 26, 2007 | Issued |
Array
(
[id] => 6348875
[patent_doc_number] => 20100248975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'Fluorogenic peptide substrate arrays for highly multiplexed, real-time monitoring of kinase activities'
[patent_app_type] => utility
[patent_app_number] => 11/647579
[patent_app_country] => US
[patent_app_date] => 2006-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11220
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20100248975.pdf
[firstpage_image] =>[orig_patent_app_number] => 11647579
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/647579 | Fluorogenic peptide substrate arrays for highly multiplexed, real-time monitoring of kinase activities | Dec 28, 2006 | Abandoned |
Array
(
[id] => 5733472
[patent_doc_number] => 20060258589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Methods for enhancing radiation therapy'
[patent_app_type] => utility
[patent_app_number] => 11/490623
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4981
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258589.pdf
[firstpage_image] =>[orig_patent_app_number] => 11490623
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/490623 | Methods for enhancing radiation therapy | Jul 20, 2006 | Abandoned |
Array
(
[id] => 5028029
[patent_doc_number] => 20070269476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Engineered extracellular matrices control stem cell behavior'
[patent_app_type] => utility
[patent_app_number] => 11/435635
[patent_app_country] => US
[patent_app_date] => 2006-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 33435
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11435635
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/435635 | Engineered extracellular matrices control stem cell behavior | May 15, 2006 | Abandoned |
Array
(
[id] => 4798025
[patent_doc_number] => 20080009611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Method for Producing Protein Hydrolysates'
[patent_app_type] => utility
[patent_app_number] => 11/793822
[patent_app_country] => US
[patent_app_date] => 2005-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3502
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009611.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793822
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793822 | Method for producing protein hydrolysates | Dec 22, 2005 | Issued |